Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Nutriband Inc. (NTRB)
A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.89HealthcareDelayed quote: Oct 6, 2026, 3:09 PM EDT
NTRB
Nutriband Inc.
$6.71HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — ACRV vs NTRB
growth of $100 · dividends reinvested · last 4yACRV -88.1% (-41.3%/yr)NTRB +66.0% (+13.5%/yr)NTRB compounded faster over this window
Log scale — wide-divergence pair
ACRV NTRB
ACRV vs NTRB: by the numbers
- •NTRB is the larger company ($82M vs $81M market cap).
- •Both run net losses; ACRV's is the smaller (0.00% vs -430.43% net margin).
Metrics side by side
Valuation
| Metric | ACRV | NTRB |
|---|---|---|
| Forward P/E | N/A | 4.27 |
| P/S ratio | N/A | 50.42 |
| P/B ratio | 0.93 | 15.32 |
Profitability
| Metric | ACRV | NTRB |
|---|---|---|
| Gross margin | 0.00% | 33.14% |
| Operating margin | 0.00% | -408.41% |
| Net margin | 0.00% | -430.43% |
| ROE | -85.65% | -130.67% |
| ROIC | -88.28% | -126.99% |
Growth (annualized)
| Metric | ACRV | NTRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.12% |
| Total return CAGR (5Y) | N/A | 6.67% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.